Matches in Nanopublications for { ?s ?p "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP103135.RAA5QZmkTIawDCgKA-wM-agy5Qs48T8zemdubqCsbY5U0130_assertion description "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103135.RAA5QZmkTIawDCgKA-wM-agy5Qs48T8zemdubqCsbY5U0130_provenance.
- NP119821.RAjIQMCkvuj83RcKmIGsqo_x0OMOFiFWs4uoEHqy1ry2Y130_assertion description "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119821.RAjIQMCkvuj83RcKmIGsqo_x0OMOFiFWs4uoEHqy1ry2Y130_provenance.
- NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_assertion description "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_provenance.
- NP166357.RAQ-J8KON3U3tSySPG5AfWmCtooU7Q7vmTmmpnay29idM130_assertion description "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166357.RAQ-J8KON3U3tSySPG5AfWmCtooU7Q7vmTmmpnay29idM130_provenance.
- NP183015.RAtWoLE-xTKoxy4cXJ4PEutJyrUzBYOaldcdAmspaHAXk130_assertion description "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183015.RAtWoLE-xTKoxy4cXJ4PEutJyrUzBYOaldcdAmspaHAXk130_provenance.
- assertion description "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP204622.RAB5CZ81PwMfCjUeWqTXkHYa9vMluVr_wDeyoe7OnNj7k130_assertion description "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204622.RAB5CZ81PwMfCjUeWqTXkHYa9vMluVr_wDeyoe7OnNj7k130_provenance.
- NP179837.RA8J7Z40Ea8b4fbPB2W5b-bQT-VNDsDtG2E923j15SiW8130_assertion description "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP179837.RA8J7Z40Ea8b4fbPB2W5b-bQT-VNDsDtG2E923j15SiW8130_provenance.
- NP204624.RAJUXlvcLwjYGJHIK9RnSJ9Hx8dNxPijpqy0Gkpcy9OHg130_assertion description "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204624.RAJUXlvcLwjYGJHIK9RnSJ9Hx8dNxPijpqy0Gkpcy9OHg130_provenance.
- NP204623.RA3qT6rVccAUisVHXaOy6dE2jOTnzDX88TBmBAoSYhRs4130_assertion description "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204623.RA3qT6rVccAUisVHXaOy6dE2jOTnzDX88TBmBAoSYhRs4130_provenance.